173 related articles for article (PubMed ID: 12679136)
1. Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
Krusekopf S; Roots I; Kleeberg U
Eur J Pharmacol; 2003 Apr; 466(1-2):7-12. PubMed ID: 12679136
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
3. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
[TBL] [Abstract][Full Text] [Related]
4. Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.
Krusekopf S; Kleeberg U; Hildebrandt AG; Ruckpaul K
Xenobiotica; 1997 Jan; 27(1):1-9. PubMed ID: 9041675
[TBL] [Abstract][Full Text] [Related]
5. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
6. Intergenic mRNA molecules resulting from trans-splicing.
Finta C; Zaphiropoulos PG
J Biol Chem; 2002 Feb; 277(8):5882-90. PubMed ID: 11726664
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
Krusekopf S; Roots I; Hildebrandt AG; Kleeberg U
Xenobiotica; 2003 Feb; 33(2):107-18. PubMed ID: 12623754
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
[TBL] [Abstract][Full Text] [Related]
9. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor.
Usui T; Saitoh Y; Komada F
Biol Pharm Bull; 2003 Apr; 26(4):510-7. PubMed ID: 12673034
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
Lorentzon P; Bayati A; Lee H; Andersson K
Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
[No Abstract] [Full Text] [Related]
11. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
[TBL] [Abstract][Full Text] [Related]
12. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450.
Domanski TL; Finta C; Halpert JR; Zaphiropoulos PG
Mol Pharmacol; 2001 Feb; 59(2):386-92. PubMed ID: 11160876
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
[TBL] [Abstract][Full Text] [Related]
14. Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.
Maruyama M; Matsunaga T; Harada E; Ohmori S
Biol Pharm Bull; 2007 Nov; 30(11):2091-7. PubMed ID: 17978482
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and their drug interactions: an evidence-based approach.
Gerson LB; Triadafilopoulos G
Eur J Gastroenterol Hepatol; 2001 May; 13(5):611-6. PubMed ID: 11396546
[TBL] [Abstract][Full Text] [Related]
16. Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.
Sarkar MA; Vadlamuri V; Ghosh S; Glover DD
Drug Metab Dispos; 2003 Jan; 31(1):1-6. PubMed ID: 12485945
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
Koch I; Weil R; Wolbold R; Brockmöller J; Hustert E; Burk O; Nuessler A; Neuhaus P; Eichelbaum M; Zanger U; Wojnowski L
Drug Metab Dispos; 2002 Oct; 30(10):1108-14. PubMed ID: 12228187
[TBL] [Abstract][Full Text] [Related]
19. Expression and induction of CYP3As in human fetal hepatocytes.
Matsunaga T; Maruyama M; Harada E; Katsuyama Y; Sugihara N; Ise H; Negishi N; Ikeda U; Ohmori S
Biochem Biophys Res Commun; 2004 May; 318(2):428-34. PubMed ID: 15120618
[TBL] [Abstract][Full Text] [Related]
20. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
Masubuchi N; Hakusui H; Okazaki O
Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
